Darolutamide (Nubeqa) – Hope for men with high-risk non-metastatic hormone resistant prostate cancer Learn More Online Community counts down to launch of new technology platform 27 May 2020 Prostate Cancer Foundation of Australia launches emergency telenursing appeal 26 May 2020 Advancing precision medicine for metastatic prostate cancer - US FDA approves new PARP inhibitors 22 May 2020 Community luminaries win prestigious prostate cancer award 19 May 2020 Could androgen deprivation therapy guard against severe COVID- 19 and related infections? 14 May 2020 Metastasis directed therapy for oligometastatic prostate cancer 08 May 2020 prev 1 2 3 4 5 6 7 8 … 18 next